Overview Dividends

(CRAI) CRA International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12618T1051

Consulting, Research, Analytics, Services

CRAI EPS (Earnings per Share)

EPS Growth (3Y CAGR): 3.36%
EPS Trend (3Y Correlation): 55.1%

CRAI Revenue

Revenue Growth (3Y CAGR): 8.73%
Revenue Trend (3Y Correlation): 93.0%

Description: CRAI CRA International

CRA International Inc (NASDAQ:CRAI) is a US-based company operating in the Research & Consulting Services sub-industry. The companys financial performance is characterized by a robust Return on Equity (RoE) of 26.90%, indicating a strong ability to generate profits from shareholder equity.

The stocks valuation multiples, including a Price-to-Earnings (P/E) ratio of 22.48 and a forward P/E of 23.42, suggest a relatively stable earnings growth trajectory. With a market capitalization of $1.22 billion, CRAI is considered a mid-cap stock, potentially offering a balance between growth and stability.

Key drivers of CRAIs financial performance may include demand for consulting services, particularly in areas such as litigation support, expert testimony, and strategic advisory services. The companys ability to attract and retain top talent, as well as its capacity to expand its service offerings, are also crucial factors influencing its growth prospects.

To evaluate CRAIs future performance, potential Key Performance Indicators (KPIs) to monitor include revenue growth, consulting margin, client acquisition rates, and employee utilization rates. Additionally, macroeconomic factors such as GDP growth, corporate profitability, and regulatory changes may impact the demand for CRAIs services, thereby influencing its stock performance.

CRAI Stock Overview

Market Cap in USD	1,291m
Sub-Industry	Research & Consulting Services
IPO / Inception	1998-04-24

CRAI Stock Ratings

Growth Rating	65.2%
Fundamental	76.9%
Dividend Rating	72.8%
Return 12m vs S&P 500	3.68%
Analyst Rating	3.50 of 5

CRAI Dividends

Dividend Yield 12m	1.29%
Yield on Cost 5y	6.17%
Annual Growth 5y	13.00%
Payout Consistency	100.0%
Payout Ratio	24.8%

CRAI Growth Ratios

Growth Correlation 3m	10.1%
Growth Correlation 12m	15.6%
Growth Correlation 5y	92.3%
CAGR 5y	37.82%
CAGR/Max DD 5y	1.14
Sharpe Ratio 12m	1.40
Alpha	2.73
Beta	1.132
Volatility	31.50%
Current Volume	119k
Average Volume 20d	76.7k
Stop Loss	190.1 (-3%)
Signal	-2.13

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (56.5m TTM) > 0 and > 6% of Revenue (6% = 42.8m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA -7.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -3.40% (prev 2.84%; Δ -6.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 36.9m <= Net Income 56.5m (YES >=105%, WARN >=100%)

Net Debt (204.4m) to EBITDA (100.3m) ratio: 2.04 <= 3.0 (WARN <= 3.5)

Current Ratio 0.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (6.75m) change vs 12m ago -2.29% (target <= -2.0% for YES)

Gross Margin 31.53% (prev 27.78%; Δ 3.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 123.7% (prev 119.5%; Δ 4.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 72.25 (EBITDA TTM 100.3m / Interest Expense TTM 1.10m) >= 6 (WARN >= 3)

Altman Z'' 2.28

(A) -0.04 = (Total Current Assets 293.1m - Total Current Liabilities 317.3m) / Total Assets 606.8m

(B) 0.34 = Retained Earnings (Balance) 206.5m / Total Assets 606.8m

(D) 0.48 = Book Value of Equity 197.0m / Total Liabilities 409.8m

Total Rating: 2.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 76.90

1. Piotroski 7.0pt = 2.0

2. FCF Yield 1.41% = 0.70

3. FCF Margin 2.96% = 0.74

4. Debt/Equity 1.17 = 1.85

5. Debt/Ebitda 2.30 = -0.59

6. ROIC - WACC 11.72% = 12.50

7. RoE 26.90% = 2.24

8. Rev. Trend 92.98% = 4.65

9. Rev. CAGR 8.73% = 1.09

10. EPS Trend 55.05% = 1.38

11. EPS CAGR 3.36% = 0.34

What is the price of CRAI shares?

As of August 30, 2025, the stock is trading at USD 196.00 with a total of 119,007 shares traded.
Over the past week, the price has changed by +2.69%, over one month by +11.01%, over three months by +4.64% and over the past year by +22.01%.

Is CRA International a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, CRA International (NASDAQ:CRAI) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 76.90 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRAI is around 228.25 USD . This means that CRAI is currently undervalued and has a potential upside of +16.45% (Margin of Safety).

Is CRAI a buy, sell or hold?

CRA International has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold CRAI.

Strong Buy: 0
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CRAI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	239.5	22.2%
Analysts Target Price	239.5	22.2%
ValueRay Target Price	254.6	29.9%

Last update: 2025-08-28 04:35

CRAI Fundamental Data Overview

Market Cap USD = 1.29b (1.29b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 19.4m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 23.7433
P/E Forward = 24.7525
P/S = 1.8113
P/B = 6.5547
P/EG = 1.5477
Beta = 0.896
Revenue TTM = 712.9m USD
EBIT TTM = 79.6m USD
EBITDA TTM = 100.3m USD
Long Term Debt = 92.5m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 138.7m USD (from shortTermDebt, last quarter)
Debt = 231.2m USD (Calculated: Short Term 138.7m + Long Term 92.5m)
Net Debt = 204.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.50b USD (1.29b + Debt 231.2m - CCE 19.4m)
Interest Coverage Ratio = 72.25 (Ebit TTM 79.6m / Interest Expense TTM 1.10m)
FCF Yield = 1.41% (FCF TTM 21.1m / Enterprise Value 1.50b)
FCF Margin = 2.96% (FCF TTM 21.1m / Revenue TTM 712.9m)
Net Margin = 7.93% (Net Income TTM 56.5m / Revenue TTM 712.9m)
Gross Margin = 31.53% ((Revenue TTM 712.9m - Cost of Revenue TTM 488.2m) / Revenue TTM)
Tobins Q-Ratio = 7.63 (Enterprise Value 1.50b / Book Value Of Equity 197.0m)
Interest Expense / Debt = -0.78% (Interest Expense -1.80m / Debt 231.2m)
Taxrate = 29.57% (from yearly Income Tax Expense: 19.6m / 66.2m)
NOPAT = 56.1m (EBIT 79.6m * (1 - 29.57%))
Current Ratio = 0.92 (Total Current Assets 293.1m / Total Current Liabilities 317.3m)
Debt / Equity = 1.17 (Debt 231.2m / last Quarter total Stockholder Equity 197.0m)
Debt / EBITDA = 2.30 (Net Debt 204.4m / EBITDA 100.3m)
Debt / FCF = 10.94 (Debt 231.2m / FCF TTM 21.1m)
Total Stockholder Equity = 210.2m (last 4 quarters mean)
RoA = 9.32% (Net Income 56.5m, Total Assets 606.8m )
RoE = 26.90% (Net Income TTM 56.5m / Total Stockholder Equity 210.2m)
RoCE = 26.31% (Ebit 79.6m / (Equity 210.2m + L.T.Debt 92.5m))
RoIC = 20.28% (NOPAT 56.1m / Invested Capital 276.5m)
WACC = 8.56% (E(1.29b)/V(1.52b) * Re(10.19%)) + (D(231.2m)/V(1.52b) * Rd(-0.78%) * (1-Tc(0.30)))
Shares Correlation 5-Years: -100.0 | Cagr: -2.77%
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 61.43% ; FCFE base≈36.5m ; Y1≈24.0m ; Y5≈11.0m
Fair Price DCF = 23.92 (DCF Value 157.5m / Shares Outstanding 6.58m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 92.98 | Revenue CAGR: 8.73%
Rev Growth-of-Growth: 1.77
EPS Correlation: 55.05 | EPS CAGR: 3.36%
EPS Growth-of-Growth: 31.03

Additional Sources for CRAI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle